BPG is committed to discovery and dissemination of knowledge
Observational Study
©The Author(s) 2026.
World J Methodol. Mar 20, 2026; 16(1): 107203
Published online Mar 20, 2026. doi: 10.5662/wjm.v16.i1.107203
Table 1 Changes of outcome measures at different time points
Outcome measures
Groups
Mean
SD
P value
VAS at baseline Amitriptyline 7.9213 0.5579 < 0.0001
Duloxetine 8.4646 0.7948
VAS at 1 week Amitriptyline 0.9145 0.6375 < 0.0001
Duloxetine 4.0394 1.2306
VAS at 4 weeks Amitriptyline 1.0000 0.9913 < 0.0001
Duloxetine 1.5984 0.9450
VAS at 12 weeksAmitriptyline 1.87401.7182 < 0.0001
Duloxetine0.9213 0.7828
BPI at baselineAmitriptyline 8.5118 1.1606 0.1156
Duloxetine 8.2913 1.0624
BPI at 1 weekAmitriptyline 6.4016 1.2036 0.8234
Duloxetine 6.3701 1.0374
BPI at 4 weeksAmitriptyline 4.4409 0.7309 0.7319
Duloxetine 4.4724 0.7328
BPI at 12 weeksAmitriptyline 0.1803 0.7109 0.1803
Duloxetine 2.0157 0.6899